The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis. [electronic resource]
Producer: 20011204Description: 530-6 p. digitalISSN:- 0091-6749
- 3',5'-Cyclic-AMP Phosphodiesterases -- antagonists & inhibitors
- Aminopyridines -- adverse effects
- Benzamides -- adverse effects
- Cyclic Nucleotide Phosphodiesterases, Type 4
- Cyclopropanes
- Female
- Headache -- chemically induced
- Humans
- Male
- Nasal Provocation Tests
- Phosphodiesterase Inhibitors -- adverse effects
- Rhinitis, Allergic, Seasonal -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.